Top

Published in:

01-08-2015 | Original Research

Genetics Health Professionals’ Views on Quality of Genetic Counseling Service Provision for Presymptomatic Testing in Late-Onset Neurological Diseases in Portugal: Core Components, Specific Challenges and the Need for Assessment Tools

Authors: M. Paneque, Á. Mendes, L. Guimarães, J. Sequeiros, H. Skirton

Published in: Journal of Genetic Counseling | Issue 4/2015

Abstract

Quality assessment of genetic counseling practice for improving healthcare is a challenge for genetic services worldwide; however, there is scarce literature regarding quality issues in genetic counseling in the context of presymptomatic testing for late-onset neurological diseases (Paneque et al. 2012) The aims of this qualitative study were to: (1) explore the views of professionals’ who provide genetic counseling services for presymptomatic testing for late-onset neurological diseases regarding relevant quality indicators for counseling practice; and (2) examine current assessment of such counseling practice for Portuguese genetic services. Quality indicators are a means of measuring either the process or outcomes of patient services, with the aim of evaluating and improving quality of care (Mainz 2003). In this study, we defined quality indicators as measurable outcomes of the counseling process that may reflect good professional practice and desirable end-term effects. We undertook interviews with 18 genetic health professionals (85 % of all genetic counseling professionals involved) from the major genetic services in Portugal. Results indicate that professionals valued some core components of genetic counseling, including providing information and decision-making support, informing the consultand about the genetic counseling protocol, as well as exploring motivations, expectations for test results, consequent anticipated life changes, psychosocial adjustment, and personal and familial experience with the disease. Professionals were not, however, able to clearly elucidate quality indicators for effective practice and some reported they had not reflected on that topic before. Professionals also reported specific challenges in their practice, such as ambiguity of the health/illness status and affirming consultands’ autonomy. Results of the study have revealed a lack of knowledge about quality indicators and tools to assess counseling practice. A credible set of quality indicators for presymptomatic testing is required as a foundation for the development of specific tools.

Almqvist, E. W., Brinkman, R. R., Wiggins, S., & Hayden, M. R. (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clinical Genetics, 64(4), 300–309.PubMedCrossRef

Bernhardt, C., Schwan, A. M., Kraus, P., Epplen, J. T., & Kunstmann, E. (2009). Decreasing uptake of predictive testing for Huntington’s disease in a German centre: 12 years’ experience (1993–2004). European Journal of Human Genetics, 17(3), 295–300.PubMedCentralPubMedCrossRef

Clark, M. (2005). Health care professionals’ versus patients’ perspectives on diabetes. Journal of Diabetes Nursing, 9(3), 87–91.

Cruz, T., Reynaldo, R., Cedeño, H., Laffita, J. M., González, Y., Aguilera, R., et al. (2011). Ethical dilemmas in genetic testing: examples from Cuban program for predictive diagnosis of hereditary ataxias. Journal of Genetic Counseling, 20(3), 241–248.CrossRef

Cruz, T., Velázquez, L., González, Y., Aguilera, R., Velázquez, M., Vázquez, Y., et al. (2013). The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from. Clinical Genetics, 83(6), 518–524.CrossRef

Davey, A., Rosntant, K., Harrop, K., Goldblatt, J., & O’Leary, P. (2005). Evaluating genetic counseling: client expectations, psychological adjustment and satisfaction with service. Journal of Genetic Counseling, 14(3), 197–206.PubMedCrossRef

Decruyenaere, M., Evers-Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., Dom, R., et al. (2003). Psychological distress in the 5-year period after predictive testing for Huntington’s disease. European Journal of Human Genetics, 11(1), 30–38.PubMedCrossRef

Dufrasne, S., Roy, M., Galvez, M., & Rosenblatt, D. (2011). Experience over fifteen years with a protocol for predictive testing for Huntington disease. Molecular Genetics and Metabolism, 102(4), 494–504.PubMedCrossRef

Duisterhof, M., Trijsburg, R. W., Niermeijer, M. F., Roos, R. A., & Tibben, A. (2001). Psychological studies in Huntington’s disease: making up the balance. Journal of Medical Genetics, 38(12), 852–856.PubMedCentralPubMedCrossRef

Edwards, A., Gray, J., Clarke, A., Dundon, J., Elwyn, G., Gaaf, C., et al. (2008). Interventions to improve risk communication in clinical genetics: a systematic review. Patient Education & Counseling, 71(1), 4–25.

Ellington, L., Roter, D., Dudley, W., Baty, B., Upchurch, R., Larson, S., et al. (2005). Communication analysis of BRCA1 genetic counseling. Journal of Genetic Counseling, 14(5), 377–386.PubMedCrossRef

Evers-Kiebooms, G. (2010). Genetic counseling for late-onset disorders. In U. Kristoffersson, J. Schmidtke, & J. J. Cassiman (Eds.), Quality issues in clinical genetic services (pp. 353–360). Berlin: Springer.CrossRef

Evers-Kiebooms, G., Welkenhysen, M., Claes, E., Decruyenaere, M., & Denayer, L. (2000). The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers. Social Science & Medicine, 51(6), 831–841.CrossRef

Futter, M. J., Heckmann, J. M., & Greenberg, L. J. (2009). Predictive testing for Huntington disease in a developing country. Clinical Genetics, 75(1), 92–97.PubMedCrossRef

Garland, A. F., Kruse, M., & Aarons, G. A. (2003). Clinicians and outcome measurement: what’s the use? Journal of Behavioral Health Services & Research, 30, 393–405.CrossRef

Guimarães, L., Sequeiros, J., Skirton, H., & Paneque, M. (2013). What counts as successful in genetic counseling for presymptomatic testing in late-onset disorders? The consultands perspective. Journal of Genetic Counseling, 22(4), 437–447.PubMedCrossRef

HDSA (2003). Genetic Testing for Huntington’s Disease: Its Relevance and Implications. US Huntington’s Disease Genetic Testing Group Revised. Retrieved from https://www.hdsa.org/living-withhuntingtons/publications/index.html.

Higgins, S., Veach, P. M., MacFarlane, I. M., Borders, L. D., LeRoy, B., & Callanan, N. (2013). Genetic counseling supervisor competencies: results of a Delphi study. Journal of Genetic Counseling, 22(1), 39–57.CrossRef

International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea. (1994a). Guidelines for the molecular genetics predictive test in Huntington’s disease. Neurology, 44(8), 1533–1536.CrossRef

International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea. (1994b). Guidelines for the molecular genetics predictive test in Huntington’s disease. Journal of Medical Genetics, 31(7), 555–559.CrossRef

Kosonen, J., Rantanen, E., Hietala, M., Kristoffersson, U., Nippert, I., Schmidtke, J., & Kääriäinen, H. (2008). Have patient’s opinion been asked? A review of 102 studies from the years 1997–2007 on patient perspective of genetic counseling services in genetic testing situations. EuroGentest Report.

MacLeod, R., Tibben, A., Frontali, M., Evers-Kiebooms, G., Jones, A., Martinez-Descales, A., Roos, R. A., & Editorial Committee and Working Group ‘Genetic Testing Counseling’ of the European Huntington’s Disease Network. (2013). Recommendations for the predictive genetic test in Huntington’s disease. Clinical Genetics, 83(3), 221–231.PubMedCrossRef

Mainz, J. (2003). Defining and classifying clinical indicators for quality improvement. International Journal for Quality in Health Care, 15(6), 523–530.PubMedCrossRef

McAllister, M. (2001). Grounded theory in genetic counseling research. Journal of Genetic Counseling, 10(3), 233–250.CrossRef

McAllister, M., Payne, K., Nicholls, S., MacLeod, R., Donnai, D., & Davies, L. M. (2007). Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families. Journal of Genetic Counseling, 16(1), 71–83.PubMedCrossRef

McAllister, M., Dunn, G., & Todd, C. (2010). Empowerment: qualitative underpinning of a new clinical genetics-specific patient-reported outcome. European Journal of Human Genetics, 19(2), 125–130.PubMedCentralPubMedCrossRef

McCarthy Veach, P., Bartels, D. M., & LeRoy, B. S. (2007). Coming full circle: a reciprocal-engagement model of genetic counseling practice. Journal of Genetic Counseling, 16(6), 713–728.CrossRef

Meiser, B., Irle, J., Lobb, E., & Barlow-Stewart, K. (2008). Assessment of the content and process of genetic counseling: a critical review of empirical studies. Journal of Genetic Counseling, 17(5), 434–451.PubMedCrossRef

Mendes, Á., Sousa, L., & Paneque, M. (2013). From constraints to opportunities? Provision of psychosocial support in Portuguese oncogenetic counseling services. Journal of Genetic Counseling, 22(6), 771–783.PubMedCrossRef

Paneque, M., Sequeiros, J., & Skirton, H. (2012). Quality assessment of genetic counseling process in the context of presymptomatic testing for late-onset disorders: a thematic analysis of three review articles. Genetic Testing and Molecular Biomarkers, 16(1), 36–45.PubMedCrossRef

Payne, K., Nicholls, S., McAllister, M., MacLeod, R., Ellis, I., Donnai, D., et al. (2007). Outcome measures for clinical genetics services: a comparison of genetics healthcare professionals and patients’ views. Health Policy, 84(1), 112–22.PubMedCrossRef

Payne, K., Nicholls, S., McAllister, M., MacLeod, R., Donnai, D., & Davies, L. (2008). Outcome measurement in clinical genetics services: a systematic review of validated measures. Value in Health, 11(3), 497–508.PubMedCrossRef

Resta, R. G. (2006). Defining and redefining the scope and goals of genetic counseling. American Journal of Medical Genetics, 142C, 269–275.PubMedCrossRef

Rodrigues, C. S., de Oliveira, V. Z., Camargo, G., Osório, C. M., de Castilhos, R. M., Saraiva-Pereira, M. L., et al. (2012). Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing. Journal of Genetic Counseling, 21(1), 101–112.PubMedCrossRef

Rolim, L., Leite, A., Ledo, S., Paneque, M., Sequeiros, J., & Fleming, M. (2006). Psychological aspects of presymptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I. Clinical Genetics, 69(4), 297–305.PubMedCrossRef

Royal College of General Practitioners (2013) Audit Guidance. Availbale at: http://www.rcgp.org.uk/clinical-and-research/clinical-resources/clinical-audit/audit-guidance.aspx, accessed 27 January 2014.

Silva, S. A., Costa, P. L., Costa, R., Tavares, S. M., Leite, E. S., & Passos, A. M. (2013). Meanings of quality of care: perspectives of Portuguese health professionals and patients. British Journal of Health Psychology, 18, 858–873. doi:10.1111/bjhp.12031.PubMedCrossRef

Sivell, S., Elwyn, G., Gaff, C., Clarke, A. J., Iredale, R., Shaw, C., Dundon, J., Thornton, H., & Edwards, A. (2008). How risk is perceived, constructed and interpreted by clients in clinical genetics, and effects on decision making: systematic review. Journal of Genetic Counseling, 17(1), 30–63.PubMedCrossRef

Skirton, H., Goldsmith, L., Jackson, L., & Tibben, A. (2013). Quality in genetic counseling for presymptomatic testing – clinical guidelines for practice across the range of genetic conditions. European Journal of Human Genetics, 21(3), 256–260.PubMedCentralPubMedCrossRef

Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks: Sage.

Tibben, A. (2007). Predictive testing for Huntington’s disease. Brain Research Bulletin, 72(2–3), 165–171.PubMedCrossRef

Timman, R., Roos, R., Maat-Kievit, A., & Tibben, A. (2004). Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7–10 years after the test. Health Psychology, 23(2), 189–197.PubMedCrossRef

Wang, C., Gonzalez, R., & Merajver, S. D. (2004). Assessment of genetic testing and related counseling services: current research and future directions. Social Science & Medicine, 58, 1427–1442.CrossRef

Williams, M. S. (2009). Quality in clinical genetics. American Journal of Medical Genetics, 151C, 175–178.PubMedCrossRef

Zellerino, B. C., Milligan, S. A., Gray, J. R., Williams, M. S., & Brooks, R. (2009). Identification and prioritization of quality indicators in clinical genetics: an international survey. American Journal of Medical Genetics, 151C, 179–190.PubMedCrossRef

Title: Genetics Health Professionals’ Views on Quality of Genetic Counseling Service Provision for Presymptomatic Testing in Late-Onset Neurological Diseases in Portugal: Core Components, Specific Challenges and the Need for Assessment Tools
Authors: M. Paneque
Á. Mendes
L. Guimarães
J. Sequeiros
H. Skirton
Publication date: 01-08-2015
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 4/2015
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-014-9784-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Genetics Health Professionals’ Views on Quality of Genetic Counseling Service Provision for Presymptomatic Testing in Late-Onset Neurological Diseases in Portugal: Core Components, Specific Challenges and the Need for Assessment Tools

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2015

The Long and Short of Genetic Counseling Summary Letters: A Case–control Study

Health-Related Quality of Life in Patients with MPS II

Complexities of Genetic Counseling for ALS: A Case of Two Siblings with Discordant Genetic Test Results

Perceptions of Latinas on the Traditional Prenatal Genetic Counseling Model

Reduced Uptake of Family Screening in Genotype-Negative Versus Genotype-Positive Long QT Syndrome

Genetic Counseling for Indigenous Australians: an Exploratory Study from the Perspective of Genetic Health Professionals